Biobizkaia
Forschungszentrum
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitari Germans Trias i Pujol (438)
2024
-
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 821-833
-
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Journal of Neurology, Vol. 271, Núm. 9, pp. 5813-5824
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy
Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 246-252
-
Association between early echocardiography screening of low systemic blood flow and intraventricular hemorrhage in preterm infants: a multicenter cohort study
Journal of Perinatology, Vol. 44, Núm. 10, pp. 1496-1503
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
-
Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 727-733
-
Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study
Gastroenterologia y Hepatologia
-
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Journal of medical economics, Vol. 27, Núm. 1, pp. 109-125
-
Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
Neuromuscular Disorders, Vol. 34, pp. 1-8
-
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Therapeutic Advances in Gastroenterology, Vol. 17
-
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
-
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study
Eye (Basingstoke)
-
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
ERJ Open Research, Vol. 10, Núm. 1
-
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pituitary, Vol. 27, Núm. 5, pp. 497-506
-
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 750-758
-
Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch
Transplantation, Vol. 108, Núm. 3, pp. 787-801
-
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
RMD open, Vol. 10, Núm. 1
-
Increased Severity of Mycoplasma pneumoniae Infections in Spanish Children
Pediatric Infectious Disease Journal